pipeline | autoimmune/inflammation | oncology
A Phase I healthy volunteer study for ALPN-101 is currently enrolling. ALPN-202 is targeted to file an IND or equivalent later in 2019.
In case you missed the release this morning, we'll be presenting one week from today.
Yesterday at 6:36 pm
Alpine Immune Sciences Provides Pipeline Update &
Reports Second Quarter 2019 Financial Results. ALPN-101 Progresse… twitter.com/i/web/status/11612…
August 13, 2019 11:34 am
© 2019 Alpine Immune Sciences.
All Rights Reserved, Alpine Immune Sciences Inc.